Leidos Partnership Delivers MHS GENESIS to Level 1 Trauma Center in Texas
The Leidos Partnership for Defense Health announced the successful deployment of the MHS GENESIS electronic health record system to over 19,000 clinicians in Texas, marking its largest deployment yet across 100 locations. This system is operational at over 1,300 locations with roughly 85,000 active users. The initiative has remained on schedule and budget despite COVID-19 challenges. Full deployment is expected by the end of 2023, serving to enhance healthcare delivery in military settings.
- Successful delivery of MHS GENESIS to over 19,000 clinicians in Texas.
- System operational at over 1,300 locations with approximately 85,000 active users.
- Deployment remains on schedule and budget despite COVID-19 challenges.
- Full deployment expected by the end of 2023.
- None.
RESTON, Va., Jan. 26, 2022 /PRNewswire/ -- The Leidos Partnership for Defense Health (LPDH) today announced it successfully delivered the MHS GENESIS electronic health record to an additional 19,000+ clinicians and providers as part of its largest Wave deployment to date, spanning 100 locations in Texas.
"MHS GENESIS is now live and operational in the only Level 1 Trauma Center in the Defense Department," said Liz Porter, Leidos Health Group president. "It is a great honor knowing the system will enable clinicians and providers to continue delivering advanced care to several thousand trauma and burn patients in Central San Antonio."
LPDH developed MHS GENESIS, the Military Health System's new electronic health record, and has been providing program management and technical expertise to the Program Executive Office Defense Healthcare Management Systems (PEO DHMS) since 2015.
The MHS GENESIS system is now operational at more than 1,300 locations with approximately 85,000 total active users — approximately
"The program has continued to operate both on schedule and on budget, despite facing unforeseen challenges due to the COVID-19 Pandemic," notes Holly Joers, PEO DHMS. "We are extremely proud of the team's continued commitment to the mission and ability to react and respond to these real-world events."
MHS GENESIS is being deployed across the continental United States and overseas through a total of 23 waves. Each Wave will target a specific region over one year, with an average of three hospitals and numerous physical locations for each Wave. This approach enables the DOD to take full advantage of lessons learned from prior Waves to maximize subsequent Waves' efficiencies. Full deployment of MHS GENESIS is expected by the end of calendar year 2023.
About Leidos
Leidos is a Fortune 500® technology, engineering, and science solutions and services leader working to solve the world's toughest challenges in the defense, intelligence, civil, and health markets. The company's 43,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Va., Leidos reported annual revenues of approximately
About LPDH
The Leidos Partnership consists of four core partners - Leidos, Cerner Corporation, Accenture and Henry Schein One - along with approximately 30 supporting businesses. Together, they deliver an integrated, modern, secure health information system that includes an electronic health record system, a dental system, identity management capability, Cybersecurity, and other supporting components. MHS GENESIS will serve as the system of record, providing a single, integrated solution for managing the health and military readiness of the force for DOD and the Department of Veterans Affairs.
Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company's Annual Report on Form 10-K for the period ended January 1, 2021, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.
Contact:
Melissa Dueñas
(571) 526-6850
Melissa.L.Duenas@leidos.com
Thomas Doheny
(571) 474-4735
Dohenyt@leidos.com
Brandon VerVelde
(571) 526-6257
Brandon.p.vervelde@leidos.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/leidos-partnership-delivers-mhs-genesis-to-level-1-trauma-center-in-texas-301468374.html
SOURCE Leidos
FAQ
What is MHS GENESIS announced by Leidos?
How many clinicians received MHS GENESIS in Texas?
When is the full deployment of MHS GENESIS expected?
How many locations are involved in the MHS GENESIS deployment?
What benefits does MHS GENESIS offer to military healthcare?
